Portable flanking sequences modulate CTL epitope processing.
about
Variable fitness impact of HIV-1 escape mutations to cytotoxic T lymphocyte (CTL) responseMechanisms of HIV protein degradation into epitopes: implications for vaccine designSAMHD1 Limits HIV-1 Antigen Presentation by Monocyte-Derived Dendritic Cells.Conserved epitopes of influenza A virus inducing protective immunity and their prospects for universal vaccine developmentConservation and diversity of influenza A H1N1 HLA-restricted T cell epitope candidates for epitope-based vaccines.A human immune data-informed vaccine concept elicits strong and broad T-cell specificities associated with HIV-1 control in mice and macaques.CTL escape mediated by proteasomal destruction of an HIV-1 cryptic epitopeAdvances in the design and delivery of peptide subunit vaccines with a focus on toll-like receptor agonistsThe antiviral efficacy of HIV-specific CD8⁺ T-cells to a conserved epitope is heavily dependent on the infecting HIV-1 isolate.Protective efficacy of serially up-ranked subdominant CD8+ T cell epitopes against virus challengesMolecular characterization of HIV-1 CRF01_AE in Mekong Delta, Vietnam, and impact of T-cell epitope mutations on HLA recognition (ANRS 12159).HIV-1 adaptation to NK-cell-mediated immune pressureSpontaneous control of HCV is associated with expression of HLA-B 57 and preservation of targeted epitopes.The T-cell response to HIV.HIV-1 p24(gag) derived conserved element DNA vaccine increases the breadth of immune response in mice.Location of the CD8 T cell epitope within the antigenic precursor determines immunogenicity and protection against the Toxoplasma gondii parasite.A simple methodology to assess endolysosomal protease activity involved in antigen processing in human primary cells.Variable HIV peptide stability in human cytosol is critical to epitope presentation and immune escape.Comparison of immune responses generated by optimized DNA vaccination against SIV antigens in mice and macaquesMultimodality vaccination against clade C SHIV: partial protection against mucosal challenges with a heterologous tier 2 virus.DNA/Ad5 vaccination with SIV epitopes induced epitope-specific CD4⁺ T cells, but few subdominant epitope-specific CD8⁺ T cellsBroad CTL response is required to clear latent HIV-1 due to dominance of escape mutationsVariable processing and cross-presentation of HIV by dendritic cells and macrophages shapes CTL immunodominance and immune escape.A Conserved HIV-1-Derived Peptide Presented by HLA-E Renders Infected T-cells Highly Susceptible to Attack by NKG2A/CD94-Bearing Natural Killer Cells.Elite controllers with low to absent effector CD8+ T cell responses maintain highly functional, broadly directed central memory responses.The saga of MHC-bound peptides: a renaissance for antigen presentation?The presence of prolines in the flanking region of an immunodominant HIV-2 gag epitope influences the quality and quantity of the epitope generated.Differential antigen presentation kinetics of CD8+ T-cell epitopes derived from the same viral protein.Host ethnicity and virus genotype shape the hepatitis B virus-specific T-cell repertoire.Differential HIV epitope processing in monocytes and CD4 T cells affects cytotoxic T lymphocyte recognitionEnhanced antigen processing of flagellin fusion proteins promotes the antigen-specific CD8+ T cell response independently of TLR5 and MyD88.Analysis of Major Histocompatibility Complex-Bound HIV Peptides Identified from Various Cell Types Reveals Common Nested Peptides and Novel T Cell Responses.A real-time killing assay to follow viral epitope presentation to CD8 T cellsPreinfection human immunodeficiency virus (HIV)-specific cytotoxic T lymphocytes failed to prevent HIV type 1 infection from strains genetically unrelated to viruses in long-term exposed partners.HIV and HLA class I: an evolving relationshipSequence-specific alterations of epitope production by HIV protease inhibitors.HIV-1 adaptation to NK cell-mediated immune pressure.MHC I presentation of Toxoplasma gondii immunodominant antigen does not require Sec22b and is regulated by antigen orientation at the vacuole membrane.Different antigen-processing activities in dendritic cells, macrophages, and monocytes lead to uneven production of HIV epitopes and affect CTL recognition.Sequence evolution and escape from specific immune pressure of an HIV-1 Rev epitope with extensive sequence similarity to human nucleolar protein 6.
P2860
Q21131580-4C7E8B86-EBC1-4FD3-969C-F6CCDACF79EDQ26866505-6512B0FF-DEBE-4CB4-A5D7-44A4C639609DQ27321665-B350B496-51A0-41F8-AA15-0337FCA2312FQ30226873-FECDE739-EDF2-4B23-A85E-AC56DBD9B708Q30384675-D6912AF9-062E-4B9E-9E61-81ED40B9CAD8Q30934059-3FE57A1C-8881-4412-A968-CDCB0429862EQ31010282-7B4EDA18-B8FB-40B1-8032-4EF70574B54EQ33721641-884C52CD-B5D6-48C8-BBCF-2A135E322FB4Q33904028-C59B693F-82A3-4BAE-AFC8-FCFE8D70B60FQ33916635-662492A8-7869-4BBF-8435-F10903A00AF3Q34062308-6D6AD836-1CB6-448C-BA22-61FCB095490BQ34205851-251EDA31-2694-46AA-897F-5891A795EB6EQ34493947-8E841508-5037-479F-AA47-D888AAE0E8A2Q34642996-33B522DD-8218-45D0-AFE4-747FC71DFAEBQ34653619-657CFD1E-E2C4-4F82-90C4-82FD056C7E94Q34789311-F8BDD435-D718-4DFB-B028-9CE9FC0F6E83Q34927961-E89D79E0-DA86-4B45-9FEF-11517740C442Q35015691-3A5724E6-AD41-48C4-B742-51FA23CFE9BBQ35046349-9F330AE5-E03B-49A2-BB52-598DD33B3CD9Q35129224-958D1E9F-5434-4249-8E0E-EAB58E9BEAAFQ35269145-4CC486BC-4DC1-4BB7-A195-CD9C377D3991Q35521811-4D482267-C5EB-4E36-86F4-340FA5620918Q35579689-FCE0ACBF-4525-4BFE-8688-57D3FDC16EE8Q35909272-9A4998AD-4966-49C9-8226-86B0ABEBBB15Q36086732-421CB0DA-3378-4000-A07C-FAF62D5DB318Q36099462-198BF8DB-6ACA-43B1-BBFD-B6555C57BDD4Q36799875-D2E23B50-4AFC-4167-A92A-0E3108D6683FQ36898739-F434E74A-931F-4FE7-AAA4-04147CED2704Q36949834-BB0757E8-EC03-4E04-AF0E-62FED77371EDQ37047159-EC2EB997-E980-4ACF-BB6C-3B64210158F9Q37095534-536A8D39-22BF-4B4A-8ECF-62025C385C4BQ37253013-C00FC2B0-9D26-41D7-B241-EF750140F0AFQ37352748-BBEEA2C3-EB80-49D3-BD8E-0F10656EA292Q37365402-08DEF6E1-5A69-4544-AC5A-74AC280070A4Q38045636-F9FFA542-3971-44C2-9742-F5AC18DA6796Q38710071-01476BD8-3258-4D59-A113-AE0A902C2469Q38743267-DBB2E568-4146-451C-A778-2A70E873CA5AQ38784040-CB809834-6FB8-410B-8023-8AC47F1953ECQ38955637-97148841-D018-4268-9A08-D6F3D097B137Q39400969-384F4D5B-7DBB-4A3F-8919-CDC4A7855BED
P2860
Portable flanking sequences modulate CTL epitope processing.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Portable flanking sequences modulate CTL epitope processing.
@ast
Portable flanking sequences modulate CTL epitope processing.
@en
type
label
Portable flanking sequences modulate CTL epitope processing.
@ast
Portable flanking sequences modulate CTL epitope processing.
@en
prefLabel
Portable flanking sequences modulate CTL epitope processing.
@ast
Portable flanking sequences modulate CTL epitope processing.
@en
P2860
P356
P1476
Portable flanking sequences modulate CTL epitope processing.
@en
P2093
Pamela Stamegna
P2860
P304
P356
10.1172/JCI32047
P407
P577
2007-11-01T00:00:00Z